Authors:
LAMHARZI N
HALMOS G
JUNGWIRTH A
SCHALLY AV
Citation: N. Lamharzi et al., DECREASE IN THE LEVEL AND MESSENGER-RNA EXPRESSION OF LH-RH AND EGF RECEPTORS AFTER TREATMENT WITH LH-RH ANTAGONIST CETRORELIX IN DU-145 PROSTATE TUMOR XENOGRAFTS IN NUDE-MICE, International journal of oncology, 13(3), 1998, pp. 429-435
Citation: N. Lamharzi et al., EXPRESSION OF MESSENGER-RNA FOR LUTEINIZING-HORMONE-RELEASING HORMONERECEPTORS AND EPIDERMAL GROWTH-FACTOR RECEPTORS IN HUMAN CANCER CELL-LINES, International journal of oncology, 12(3), 1998, pp. 671-675
Authors:
MIYAZAKI M
LAMHARZI N
SCHALLY AV
HALMOS G
SZEPESHAZI K
GROOT K
CAI RZ
Citation: M. Miyazaki et al., INHIBITION OF GROWTH OF MDA-MB-231 HUMAN BREAST-CANCER XENOGRAFTS IN NUDE-MICE BY BOMBESIN GASTRIN-RELEASING PEPTIDE (GRP) ANTAGONISTS RC-3940-II AND RC-3095/, European journal of cancer, 34(5), 1998, pp. 710-717
Citation: N. Lamharzi et al., LUTEINIZING-HORMONE-RELEASING HORMONE (LH-RH) ANTAGONIST CETRORELIX INHIBITS GROWTH OF DU-145 HUMAN ANDROGEN-INDEPENDENT PROSTATE CARCINOMAIN NUDE-MICE AND SUPPRESSES THE LEVELS AND MESSENGER-RNA EXPRESSION OF IGF-II IN TUMORS, Regulatory peptides, 77(1-3), 1998, pp. 185-192
Citation: N. Lamharzi et al., GROWTH HORMONE-RELEASING HORMONE ANTAGONIST MZ-5-156 INHIBITS GROWTH OF DU-145 HUMAN ANDROGEN-INDEPENDENT PROSTATE CARCINOMA IN NUDE-MICE AND SUPPRESSES THE LEVELS AND MESSENGER-RNA EXPRESSION OF INSULIN-LIKE-GROWTH-FACTOR-II IN TUMORS, Proceedings of the National Academy of Sciences of the United Statesof America, 95(15), 1998, pp. 8864-8868
Authors:
KOPPAN M
HALMOS G
ARENCIBIA JM
LAMHARZI N
SCHALLY AV
Citation: M. Koppan et al., BOMBESIN GASTRIN-RELEASING PEPTIDE ANTAGONISTS RC-3095 AND RC-3940-IIINHIBIT TUMOR-GROWTH AND DECREASE THE LEVELS AND MESSENGER-RNA EXPRESSION OF EPIDERMAL GROWTH-FACTOR RECEPTORS IN H-69 SMALL-CELL LUNG-CARCINOMA/, Cancer, 83(7), 1998, pp. 1335-1343
Authors:
MIYAZAKI M
NAGY A
SCHALLY AV
LAMHARZI N
HALMOS G
SZEPESHAZI K
GROOT K
ARMATIS P
Citation: M. Miyazaki et al., GROWTH-INHIBITION OF HUMAN OVARIAN CANCERS BY CYTOTOXIC ANALOGS OF LUTEINIZING-HORMONE-RELEASING HORMONE, Journal of the National Cancer Institute, 89(23), 1997, pp. 1803-1809
Authors:
SZEPESHAZI K
SCHALLY AV
HALMOS G
LAMHARZI N
GROOT K
HORVATH JE
Citation: K. Szepeshazi et al., A SINGLE IN-VIVO ADMINISTRATION OF BOMBESIN ANTAGONIST RC-3095 REDUCES THE LEVELS AND MRMA EXPRESSION OF EPIDERMAL GROWTH-FACTOR RECEPTORS IN MXT MOUSE MAMMARY CANCERS, Proceedings of the National Academy of Sciences of the United Statesof America, 94(20), 1997, pp. 10913-10918
Authors:
PINSKI J
LAMHARZI N
HALMOS G
GROOT K
JUNGWIRTH A
VADILLOBUENFIL M
KAKAR SS
SCHALLY AV
Citation: J. Pinski et al., CHRONIC ADMINISTRATION OF THE LUTEINIZING-HORMONE-RELEASING HORMONE (LHRH) ANTAGONIST CETRORELIX DECREASES GONADOTROPE RESPONSIVENESS AND PITUITARY LHRH RECEPTOR MESSENGER-RIBONUCLEIC-ACID LEVELS IN RATS, Endocrinology, 137(8), 1996, pp. 3430-3436